FMP
Biohaven Ltd.
BHVN
NYSE
Biohaven Ltd. is a clinical-stage biopharmaceutical company. The Company focuses on development of therapies for neurological and immunoscience diseases that can change current treatment paradigms.
20.37 USD
1.69 (8.3%)
We are unable to load the chart at this time.